5 Upcoming IPOs This Week: HLI, GBT, GCAA, CNFR, BOXL

8 10 15 upcoming ipos this weekThere are five upcoming IPOs this week expected to raise a combined $552 million.

The IPO market has hit a lull recently. Eight out of the 12 IPOs in the last two weeks ended their first day down or flat. Planet Fitness Inc. (NYSE: PLNT) saw no gains in its Aug. 6 debut. Amplify Snack Brands Inc. (NYSE: BETR) tumbled 10% on its first day.

According to Renaissance Capital, a manager of IPO-focused ETFs, this week will be the final push for IPOs as the market enters a four-week break expected to end in mid-September.

Leading this week's IPO calendar is Houlihan Lokey Inc. (NYSE: HLI).

Houlihan Lokey is an international investment bank that specializes in advising mid-cap M&A deals. The firm oversees all aspects of the merger process, including portfolio valuation, financial restructuring, and strategic consulting.

As a leading restructuring advisory firm, Houlihan's earnings have been consistently strong thanks to a boom in U.S. M&A activity. The company posted $600 million in revenue last year, more than competitor Moelis & Co.'s (NYSE: MC) revenue of $519 million. However, the market for mid-cap advisory firms has been weak lately, with close peers Moelis and Greenhill & Co. Inc. (NYSE: GHL) down 11.9% and 15.3% in the last year.

Houlihan will raise $300 million by selling 13.06 million shares at a $22 to $24 price range. It's valued at $1.5 billion and will make its market debut on Thursday, Aug. 13.

Here are the rest of the upcoming IPOs this week...

Four More Upcoming IPOs This Week

Global Blood Therapeutics Inc. (Nasdaq: GBT) is a clinical-stage biotech developing therapies for sickle cell disease and other blood-based conditions. The company could have the largest first-day pop out of any IPO this week as it enters a historically outperforming sector. Competing sickle cell-focused biotechs bluebird bio Inc. (Nasdaq: BLUE) and Ligand Pharmaceuticals Inc. (Nasdaq: LGND) have soared 68.8% and 76.9% in 2015, respectively. Global Blood is set for a $102 million deal by offering 6 million shares at a price range of $16 to $18. It commands a market valuation of $528 million and will hit the market on Wednesday, Aug. 12.

Money Morning Members: Keep reading for the rest of the upcoming IPOs this week. For those new to Money Morning, sign up to keep reading - it's completely free...

GC Aesthetics Plc. (Nasdaq: GCAA) provides silicone breast implants in various Latin American, European, Middle Eastern, and African countries. The company reported $55 million in sales from March 2014 to March 2015, with particularly strong cash flow in Brazil. Despite U.S. peer and 2014 IPO Sientra Inc. (Nasdaq: SIEN) gaining 40.1% this year, GC Aesthetics may price lower than expected due to its delay from last week. The company will generate $75 million by selling 5.35 million shares at a $13 to $15 price range. It's valued at $260 million and will start trading sometime this week.

[epom key="ddec3ef33420ef7c9964a4695c349764" redirect="" sourceid="" imported="false"]

Conifer Holdings Inc. (Nasdaq: CNFR) will raise $55 million by selling 4.6 million shares at an $11 to $13 price range. The insurance provider will debut on Wednesday, Aug. 12.

Boxlight Corp. (Nasdaq: BOXL) is set for a $20 million deal by offering 1.82 million shares at a price range of $10 to $12. The classroom materials producer will hit the market on Friday, Aug. 14.

Alex McGuire is an associate editor for Money Morning who writes about upcoming IPOs. Follow him on Twitter (@AlexMcGuire92) for the biggest IPO news.

How to Safely Profit from Any IPO: Investing in newly issued stocks can seem like an exciting way to earn huge profits. But with institutional investors and other Wall Street "VIPs" cheating the market for quick gains, the IPO process is a rigged game nowadays. That's why we've outlined the three best IPO investing rules to follow for any new stock. Check them out here...